GILD
Gilead Sciences Inc
NASDAQ: GILD · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$130.84
+1.55% today
Updated 2026-04-30
Market cap
$159.92B
P/E ratio
19.00
P/S ratio
5.43x
EPS (TTM)
$6.78
Dividend yield
2.44%
52W range
$93 – $156
Volume
6.1M
Gilead Sciences Inc (GILD) Insider transactions
Net insider activity
Net buying (3,809,464 shares)
Buy transactions
39
Sell transactions
61
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-15 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Sale | 3,000 | $140.96 | $422880.00 |
| 2026-04-15 | DICKINSON, ANDREW D | Chief Financial Officer | Sale | 3,000 | $140.96 | $422880.00 |
| 2026-03-27 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 10,000 | $136.82 | $1.37M |
| 2026-03-16 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Sale | 3,000 | $144.23 | $432690.00 |
| 2026-03-16 | DICKINSON, ANDREW D | Chief Financial Officer | Sale | 3,000 | $144.23 | $432690.00 |
| 2026-03-10 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Buy | 32,815 | — | — |
| 2026-03-10 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 20,026 | — | — |
| 2026-03-10 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Buy | 122,755 | — | — |
| 2026-03-10 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Buy | 20,026 | — | — |
| 2026-03-10 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 9,767 | $148.56 | $1.45M |
| 2026-03-10 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Buy | 9,590 | — | — |
| 2026-03-10 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Sale | 6,617 | — | — |
| 2026-03-10 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Buy | 35,880 | — | — |
| 2026-03-10 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Buy | 6,617 | — | — |
| 2026-03-10 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Sale | 3,216 | $148.56 | $477768.96 |
| 2026-03-10 | DICKINSON, ANDREW D | Chief Financial Officer | Buy | 9,590 | — | — |
| 2026-03-10 | DICKINSON, ANDREW D | Chief Financial Officer | Sale | 6,469 | — | — |
| 2026-03-10 | DICKINSON, ANDREW D | Chief Financial Officer | Buy | 35,880 | — | — |
| 2026-03-10 | DICKINSON, ANDREW D | Chief Financial Officer | Buy | 6,469 | — | — |
| 2026-03-10 | DICKINSON, ANDREW D | Chief Financial Officer | Sale | 3,147 | $148.56 | $467518.32 |
| 2026-03-10 | CAIN, WETTAN KEELEY M | EVP Gen Counsel, Legal & Comp | Buy | 5,050 | — | — |
| 2026-03-10 | CAIN, WETTAN KEELEY M | EVP Gen Counsel, Legal & Comp | Sale | 1,246 | — | — |
| 2026-03-10 | CAIN, WETTAN KEELEY M | EVP Gen Counsel, Legal & Comp | Buy | 18,885 | — | — |
| 2026-03-10 | CAIN, WETTAN KEELEY M | EVP Gen Counsel, Legal & Comp | Buy | 1,246 | — | — |
| 2026-03-10 | CAIN, WETTAN KEELEY M | EVP Gen Counsel, Legal & Comp | Sale | 606 | $148.56 | $90027.36 |
| 2026-03-10 | BURKHART, ERIN | SVP, Controllership | Buy | 2,355 | — | — |
| 2026-03-10 | BURKHART, ERIN | SVP, Controllership | Buy | 5,455 | — | — |
| 2026-03-10 | BERGER, DIETMAR | Chief Medical Officer | Buy | 8,415 | — | — |
| 2026-03-10 | BERGER, DIETMAR | Chief Medical Officer | Sale | 2,133 | — | — |
| 2026-03-10 | BERGER, DIETMAR | Chief Medical Officer | Buy | 31,475 | — | — |
| 2026-03-10 | BERGER, DIETMAR | Chief Medical Officer | Buy | 2,133 | — | — |
| 2026-03-10 | BERGER, DIETMAR | Chief Medical Officer | Sale | 1,063 | $148.56 | $157919.28 |
| 2026-02-27 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Buy | 38,396 | — | — |
| 2026-02-27 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 6,419 | $145.18 | $931901.43 |
| 2026-02-27 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 3,481 | $144.04 | $501386.18 |
| 2026-02-27 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 100 | $145.71 | $14571.00 |
| 2026-02-27 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Buy | 11,090 | — | — |
| 2026-02-27 | DICKINSON, ANDREW D | Chief Financial Officer | Buy | 11,090 | — | — |
| 2026-02-27 | CAIN, WETTAN KEELEY M | EVP Gen Counsel, Legal & Comp | Buy | 470 | — | — |
| 2026-02-27 | BERGER, DIETMAR | Chief Medical Officer | Buy | 8,530 | — | — |
| 2026-02-17 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Sale | 25,000 | — | — |
| 2026-02-17 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Buy | 25,000 | $66.64 | $1.67M |
| 2026-02-17 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Sale | 18,405 | $154.18 | $2.84M |
| 2026-02-17 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Sale | 9,395 | $154.91 | $1.46M |
| 2026-02-17 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Sale | 200 | $155.62 | $31124.00 |
| 2026-02-17 | DICKINSON, ANDREW D | Chief Financial Officer | Sale | 3,000 | $154.43 | $463290.00 |
| 2026-02-13 | GILEAD, SCIENCES, INC. | 10% Owner | Buy | 3,739,000 | $0.53 | $2.00M |
| 2026-02-05 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 115,640 | — | — |
| 2026-02-05 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 115,640 | $150.00 | $17.35M |
| 2026-02-03 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Buy | 131,675 | — | — |
| 2026-02-03 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 74,461 | $143.28 | $10.67M |
| 2026-02-03 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Buy | 44,867 | — | — |
| 2026-02-03 | MERCIER, JOHANNA | Chief Comm & Corp Aff Officer | Sale | 24,800 | $143.28 | $3.55M |
| 2026-02-03 | DICKINSON, ANDREW D | Chief Financial Officer | Buy | 44,867 | — | — |
| 2026-02-03 | DICKINSON, ANDREW D | Chief Financial Officer | Sale | 24,802 | $143.28 | $3.55M |
| 2026-01-28 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 5,032 | $139.54 | $702185.91 |
| 2026-01-28 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 4,968 | $140.24 | $696725.24 |
| 2026-01-23 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 115,640 | — | — |
| 2026-01-23 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Buy | 115,640 | $66.01 | $7.63M |
| 2026-01-20 | BLUESTONE, JEFFREY | Director | Sale | 5,000 | — | — |
| 2026-01-20 | BLUESTONE, JEFFREY | Director | Buy | 5,000 | $67.45 | $337250.00 |
| 2026-01-15 | MERCIER, JOHANNA | Chief Commercial Officer | Sale | 3,000 | $124.31 | $372930.00 |
| 2026-01-15 | DICKINSON, ANDREW D | Chief Financial Officer | Sale | 3,000 | $124.31 | $372930.00 |
| 2026-01-02 | BERGER, DIETMAR | Chief Medical Officer | Sale | 16,326 | — | — |
| 2026-01-02 | BERGER, DIETMAR | Chief Medical Officer | Buy | 16,326 | — | — |
| 2026-01-02 | BERGER, DIETMAR | Chief Medical Officer | Sale | 6,944 | $121.60 | $844390.40 |
| 2025-12-29 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 10,000 | $124.83 | $1.25M |
| 2025-12-15 | MERCIER, JOHANNA | Chief Commercial Officer | Sale | 3,000 | $122.00 | $366000.00 |
| 2025-12-15 | DICKINSON, ANDREW D | Chief Financial Officer | Sale | 3,000 | $122.00 | $366000.00 |
| 2025-12-10 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 10,426 | — | — |
| 2025-12-10 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Buy | 10,426 | — | — |
| 2025-12-10 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 4,931 | $121.34 | $598327.54 |
| 2025-12-10 | MERCIER, JOHANNA | Chief Commercial Officer | Sale | 3,842 | — | — |
| 2025-12-10 | MERCIER, JOHANNA | Chief Commercial Officer | Buy | 3,842 | — | — |
| 2025-12-10 | MERCIER, JOHANNA | Chief Commercial Officer | Sale | 1,814 | $121.34 | $220110.76 |
| 2025-12-10 | DICKINSON, ANDREW D | Chief Financial Officer | Sale | 3,693 | — | — |
| 2025-12-10 | DICKINSON, ANDREW D | Chief Financial Officer | Buy | 3,693 | — | — |
| 2025-12-10 | DICKINSON, ANDREW D | Chief Financial Officer | Sale | 1,745 | $121.34 | $211738.30 |
| 2025-11-28 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 6,788 | $126.84 | $861015.71 |
| 2025-11-28 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 3,212 | $125.91 | $404428.06 |
| 2025-11-28 | KRAMER, KELLY A. | Director | Sale | 2,805 | — | — |
| 2025-11-28 | KRAMER, KELLY A. | Director | Buy | 2,805 | $81.00 | $227205.00 |
| 2025-11-28 | BLUESTONE, JEFFREY | Director | Sale | 5,000 | — | — |
| 2025-11-28 | BLUESTONE, JEFFREY | Director | Buy | 5,000 | $64.92 | $324600.00 |
| 2025-11-26 | KRAMER, KELLY A. | Director | Sale | 2,806 | — | — |
| 2025-11-26 | KRAMER, KELLY A. | Director | Sale | 2,806 | $127.11 | $356670.66 |
| 2025-11-26 | GILEAD, SCIENCES, INC. | 10% Owner | Sale | 13,335,000 | — | — |
| 2025-11-26 | GILEAD, SCIENCES, INC. | 10% Owner | Buy | 13,335,000 | $0.75 | $10.00M |
| 2025-11-17 | MERCIER, JOHANNA | Chief Commercial Officer | Sale | 25,000 | — | — |
| 2025-11-17 | MERCIER, JOHANNA | Chief Commercial Officer | Sale | 25,524 | $125.83 | $3.21M |
| 2025-11-17 | MERCIER, JOHANNA | Chief Commercial Officer | Buy | 25,000 | $66.64 | $1.67M |
| 2025-11-17 | MERCIER, JOHANNA | Chief Commercial Officer | Sale | 2,476 | $126.26 | $312613.57 |
| 2025-11-17 | DICKINSON, ANDREW D | Chief Financial Officer | Sale | 2,500 | $125.23 | $313075.00 |
| 2025-11-12 | TELMAN, DEBORAH H | EVP, Corporate Affairs & GC | Sale | 35,965 | — | — |
| 2025-11-12 | TELMAN, DEBORAH H | EVP, Corporate Affairs & GC | Sale | 17,181 | — | — |
| 2025-11-12 | TELMAN, DEBORAH H | EVP, Corporate Affairs & GC | Sale | 500 | — | — |
| 2025-11-12 | TELMAN, DEBORAH H | EVP, Corporate Affairs & GC | Buy | 35,965 | $60.75 | $2.18M |
| 2025-11-12 | TELMAN, DEBORAH H | EVP, Corporate Affairs & GC | Buy | 17,181 | $75.12 | $1.29M |
| 2025-11-12 | TELMAN, DEBORAH H | EVP, Corporate Affairs & GC | Sale | 500 | $122.90 | $61452.00 |
| 2025-10-28 | O'DAY, DANIEL PATRICK | Director, Chairman & CEO | Sale | 7,978 | $119.54 | $953666.98 |